Oncology Industry
Insights & Trends

April 21, 2020

Kognitic: Stay One Step Ahead

#BeiGene presented its upcoming milestones for their #pipeline today at #JPM20, including projected approvals and submissions for #tislelizumab, #zanubrutinib, and #pamiparib. Why wait until the conference […]
April 21, 2020

Real-Time Pipeline Data… Beyond the Conference Presentation

#Roche presented its late stage pipeline today at #JPM20, with #tecentriq heading up #oncology with six anticipated indications, including expansions in #HCC, #TNBC, #bladdercancer, #melanoma, #ovariancancer, […]
April 21, 2020

CD-19 Antibody Making Waves at JPM2020

A next generation CD-19 mAb, tafasitamab is all the buzz at #JPM2020! #Incyte acquired tafasitamab from #Morphosys, who had been developing the drug under the code […]
January 11, 2020

Kognitic Team to Hear from Industry Leaders at JPM2020

#JPM2020 is right around the corner! The #Kognitic team is excited to hear from numerous industry leaders what is next for the pharma industry, including keynote […]
January 10, 2020

American Cancer Society Releases Facts & Figures for 2019

American Cancer Society Releases Facts & Figures for 2019 The American Cancer Society has released the cancer facts and figures for 2019. With almost 17 million […]
January 10, 2020

Kognitic Team Heads to JMP2020!

Kognitic is excited to be heading to #JPM2020 to discuss the latest in innovative strategy for the pharma industry! Check out our website to see how […]
January 8, 2020

Kognitic Honored by Healthcare Tech Outlook as a Top 10 Oncology Solution Provider for 2019!

Thank you Healthcare Tech Outlook for featuring Kognitic in the Top Ten Oncology Companies of 2019. We are thrilled to be listed alongside other innovative companies […]
January 8, 2020

Targeting PD-L1: A New Front Runner for Oncology?

A recent study has found that antibodies which target PD-L1 are more effective than PD-1 inhibitors at blocking PD-1/PD-L1 signaling (see link below). PD-1 has been […]
January 8, 2020

Celebrating Amgen and the Lazarex Cancer Foundation’s Support for Patient Care

We would like to celebrate Amgen’s partnership with the Lazarex Cancer Foundation, an organization which is dedicated to creating equitable access to clinical trials for all […]